title: German agency refuses to rule on drug's benefits until Pfizer discloses all trial results.
authors: Ned
authors: N
authors: Stafford
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D005858:Germany; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D000077593:Reboxetine; D015871:Scientific Misconduct / Q000331:legislation & jurisprudence*
chemical_list: D000928:Antidepressive Agents; D009025:Morpholines; D000077593:Reboxetine